Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Astellas names new head of global development

This article was originally published in Scrip

Executive Summary

Astellas Pharma has named Eric Terhaerdt senior vice-president of global development operations. Mr Terhaerdt will be located at Astellas' headquarters for the Americas in Northbrook, Illinois, and will report to Dr Bernie Zeiher, executive vice-president of global development. In this role he will be responsible for establishing the global direction of the drug development operations of Astellas in the Netherlands and the US, and will work closely with Japanese development operations to ensure global operational effectiveness and efficiency.  Prior to joining Astellas, Mr Terhaerdt spent more than 20 years with AstraZeneca, serving in a variety of global leadership roles with increasing responsibility, in the areas of clinical research, clinical development, clinical quality, strategy and performance and scientific and technical evaluations. 


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts